Amundi’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
Amundi's CSTL Position: Q3 2026 in Review
Amundi opened a new position in Castle Biosciences (CSTL) in Q3 2026: 6,247 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #1948 among its holdings. This is a return to the name: Amundi previously reported a position in CSTL as recently as Q1 2025.
Amundi first reported a position in CSTL in Q3 2021 and has held it in 5 quarters since. 202 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.
- Amundi held 6,247 shares of Castle Biosciences worth $222K as of Q3 2026.
- Castle Biosciences was a new Amundi position in Q3 2026.
- Castle Biosciences made up ﹤0.01% of Amundi's portfolio in Q3 2026, its #1948 holding.
- Amundi first reported a position in Castle Biosciences in Q3 2021 and has held it in 5 quarters since.
- 202 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.
Based on Amundi's 13F filing for Q3 2026, filed 6 Nov 2026.